Mark Van Oene in

Mark Van Oene

Chief Operating Officer at Pacific Biosciences
📍 San Diego, California, United States

Mark Van Oene serves as the President and CEO of Pacific Biosciences, following his role as COO. He previously had a long, successful tenure at Illumina, where he rose to Chief Commercial Officer, overseeing substantial global revenue growth. His scientific background includes a B.S. in Biochemistry from Western University and Ph.D. candidacy at the University of Toronto.

Outside of his executive roles, Mark appeared on a "Biotech & Breweries" podcast, suggesting an appreciation for local craft beer and casual industry discussions. He has also dedicated time to community causes, demonstrating a commitment to giving back beyond his professional sphere.

He began his career as a research scientist focusing on Cystic Fibrosis at Torontos Hospital for Sick Children.

Read the full overview →
Experience
22 Years
Current Role
Chief Operating Officer
Job Level
Leadership
Location
San Diego, California, United States
Personality Overview
Personality insights not availableWe need more social data to generate the DISC analysis and selling playbook. The professional details below are still available.
Priorities

Topics Mark cares about

Genomics in Medicine
He is focused on driving the adoption of HiFi long-read sequencing into clinical applications, particularly for rare diseases and diagnostics, to create a new standard of care.
Commercial Leadership
He has extensive experience scaling global life sciences businesses, having managed a commercial team of 1,800 and over $3 billion in revenue during his time as CCO at Illumina.
+4 more topics Login to view topics
Career

Work history

1-2021
Chief Operating Officer
Pacific Biosciences
4-2017 - 1-2021
Chief Commercial Officer
Illumina
1-2014 - 4-2017
Vice President and General Manager, Americas Commercial Operations
Illumina
1-2012 - 1-2014
Vice President, Global Sales
Illumina
4-2008 - 3-2012
Senior Director of Sales, Americas
Illumina
In the press

Media appearances

Pacific Biosciences of California CEO explores future of long‑read sequencing for newborn screening (Mendelspod). Featured in Traders Union
See now
Pacific Biosciences of California Appoints New CEO, Plans to Cut 8% of Workforce. Featured in MarketWatch
+2 more appearances Login to view media
Education
1995 - 2003
Ph.D. Candidate
University of Toronto
1991 - 1995
Bachelor of Science (B.Sc.)
Western University
Social presence
in

More profiles

Discover additional public profiles from our index.

Anders Fogelberg
Anders Fogelberg
CEO
BICO
 Nick Foster
Nick Foster
Chief Customer Officer
Cresset
 Allison Kurz
Allison Kurz
Head of Marketing Communications, Biologics
Genedata
 Jurgita Strahm
Jurgita Strahm
Vice President Global Marketing
Tecan
Unlock the full playbookSee exactly how to sell to Mark. Free, 10 seconds.